AtriCure, Inc. · 11 hours ago
Cryo Nerve Block Clinical Specialist-Louisville
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. The Cryo Nerve Block Clinical Specialist will support field sales in the cardiothoracic operating room and related departments to drive adoption of the cryo nerve block procedure, training staff and providing guidance during surgical procedures.
BiotechnologyHealth CareMedicalMedical Device
Responsibilities
Support during surgical procedures where company pain management devices are utilized
Training of surgical and OR staff personnel in the use of company pain management devices
Guidance and support for physicians during live surgical procedures, and utilization and/or operation of company technology
Follow-up with surgeon and staff on patient outcomes related to Cryo Nerve Block Therapy
Qualification
Required
Undergraduate degree in technical or scientific field or experience equivalence
Ability to communicate and collaborate effectively with people across all levels
Ability to travel 40-60%, dependent upon territory
Ability to pass account and hospital credentialing
Preferred
B2B or outside sales experience is highly desired
Experience working in an Operating Room, or hospital setting either through industry or clinical setting preferred, but not required
Benefits
Car allowance, gas and cell phone reimbursement, expense account
Health care (medical, dental, vision, health savings account) and wellness programs
401K retirement savings plus match
Volunteer Time Off (VTO): We encourage your community and philanthropic involvement
Extended Parental Leave
Discounted Employee Stock Purchase Program
Tuition Reimbursement
Medical & Dental beginning day 1 of employment
20 days of paid Parental Leave
Maternity leave, for new moms and dads
Volunteer Time off
Pet Insurance
Company
AtriCure, Inc.
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide.
Funding
Current Stage
Public CompanyTotal Funding
$201MKey Investors
U.S. Venture Partners
2020-05-12Post Ipo Equity· $175M
2005-08-05IPO
2002-06-10Series Unknown· $21M
Leadership Team
Recent News
Company data provided by crunchbase